Videos

Follow one brain tumor survivor's 28-year cancer journey and discover lessons on finding answers, resilience, integrative care, and hope.

Lynn Abbott-McCloud describes the overlooked burden of being in cancer treatment, likening it to a full-time unpaid job.

Dr. Konduri provides an overview of the current frontline treatment landscape for metastatic EGFR-positive NSCLC.

Get expert answers to the top pancreatic cancer questions, including symptoms, surgery, new treatments, hereditary risk and early diagnosis.

Elizabeth Dennis describes the testing process following a new lung cancer diagnosis. Initial tissue biopsy is sent for next-generation sequencing (NGS), although repeat tissue sampling or liquid biopsy from blood may be needed if the initial biopsy is insufficient for molecular profiling.

Learn why comprehensive biomarker testing is essential before starting any lung cancer treatment. Hear from patients and oncologists about the life-changing importance of knowing your mutation first.

Dr. Kartik Konduri introduces the program on patient experiences with EGFR-positive NSCLC, joined by Elizabeth Dennis, an advanced practice provider at Texas Oncology at Baylor Simmons Cancer Center, and Lynn Abbott-McCloud, Executive Director of LiveLung, a nonprofit lung cancer organization.

Leslie Waltke's new podcast explores how cancer labels like 'survivor,' 'patient' and 'victim' evolved — and why no single word fits everyone.

Oncology physical therapist Dr. Leslie Waltke demonstrates calf raises, a simple at-home exercise to help rebuild lower body strength during cancer treatment.

A UF Health oncologist answers the most common questions about cell therapy, from who qualifies to how it differs from chemotherapy.

Nicholas Hornstein, MD, PhD discusses ctDNA in colorectal cancer, the INTERCEPT-TT trial, building Northwell's GI oncology program, and what better drugs will look like.

The discussion concludes with examination of recent research developments, particularly the CROWN trial's 7-year follow-up data presented at the American Society of Clinical Oncology meeting. Dr. Florez explains that this trial has changed ALK-positive treatment paradigms by demonstrating unprecedented durability of response with lorlatinib compared to previous standard crizotinib therapy.

The segment explores concepts of living well with cancer, advocacy, and community building for young patients facing long-term therapy. Dr. Florez notes that current reality for many young patients with ALK-positive disease involves years rather than months of survival, fundamentally changing perspectives on living with versus dying from cancer.

Susan Yaguda, oncology nurse at Atrium Health Levine Cancer Institute, transforms cancer care by treating the whole person — mind, body, and spirit — one patient at a time.

A pediatric oncologist opens up about what draws her to one of medicine's hardest jobs, and what keeps her going.

Tammy Zinn, a finalist for the Extraordinary Healer Award, reflects on the personal loss that led her to oncology nursing and the programs she built to support patients.

The discussion addresses practical aspects of living with ALK-positive disease, emphasizing that long-term oral therapy has transformed treatment possibilities from months to potentially decades of survival.

The discussion addresses practical aspects of living with ALK-positive disease, emphasizing that long-term oral therapy has transformed treatment possibilities from months to potentially decades of survival.

Oncology nurse Jill Winther discusses why understanding treatment reasoning and advocating for patients matters most in cancer care.

10 Things That Got Me Through Treatment ft. Kiana Wooten

A pediatric oncologist explains how scalp cooling, fertility preservation and early planning protect children with cancer well beyond treatment.

After surviving breast cancer and relapsed non-Hodgkin lymphoma, Maitte Penalver is helping Hispanic patients with cancer feel seen, heard and supported through advocacy and education.

The former Real Housewives star opens up about her melanoma journey, the nurses who kept her sane, and why vulnerability might be the most powerful health tool there is.

Survivorship coach Eileen Lopez Tomei discusses the unique cultural barriers Hispanic and Latina cancer survivors face and why bilingual community events matter.

Oncology PT Dr. Leslie Waltke shares a simple at-home exercise to help cancer patients and survivors rebuild strength, balance, and mobility

After a stage 4 colon cancer diagnosis at age 40, survivor Kasia Orzechowska now advocates for early screening and self-advocacy to help save lives.

New data show a leukemia treatment working better in real patients than expected with response rates nearly double what trials showed. Here's what it could mean for you.

Dr. Florez introduces shared decision-making as a collaborative approach ensuring patient voices, values, and goals become integral components of treatment planning, particularly crucial for young patients facing long-term therapy with implications spanning treatment selection, side effect management, and family dynamics.

The discussion transitions to biomarker testing as an essential component of lung cancer diagnosis, with Dr. Florez emphasizing that diagnosis remains incomplete until molecular characterization is performed.

In this episode of The Moonlight Shift, Joshua Richter, MD, associate professor of medicine in The Tisch Cancer Institute, Division of Hematology and Medical Oncology, and director of Multiple Myeloma at the Blavatnik Family- Chelsea Medical Center at Mount Sinai, joins host Gina Mauro for a conversation about a disease he says he can no longer describe the way he once did — and why that change is one of the most remarkable shifts in modern oncology.